Atlas Trials

Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Clinical trial NCT00041041 · COMPLETED

Trial details

NCT number
NCT00041041
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Start date
2002-06-01
Primary completion
2007-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.